RECRUITING

Brain Training for Substance Use Disorders

Conditions

Opioid Use Disorder biofeedback neurofeedback electroencephalogram addiction substance use disorder attention emotion regulation event-related potential

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game performance and guides game difficulty.

Official Title

Brain Training for Substance Use Disorders

Quick Facts

Study Start:2025-01-17

Study Completion:2025-08-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06870110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Admitted into chemical treatment with opioid use being a reason for treatment; * DSM-IV-TR diagnosis of OUD; * Ability to provide informed consent; * A minimum of a 6th grade reading level; and * Able and willing to provide own contact information for follow-up visit(s). * Age- and gender-matched to an OUD patient participant in the study; * Ability to provide informed consent; * A minimum of a 6th grade reading level; * Able and willing to provide own contact information for follow-up visit(s).	* Refusal or inability to consent; * Pregnant; * History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures not caused by withdrawal from substances, Other \[please specify\]); * Inability to see text and photos clearly on the computer display; and * Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary. * Refusal or inability to consent; * Pregnant; * History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures, Other \[please specify\]); * Inability to see text and photos clearly on the computer display; * Current or previous problems using opioids, other prescription (prescribed or not prescribed) or illicit drugs; * Regular nicotine user (e.g., cigarette smoker, e-cig user) within the past 12 months; and * Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.

Inclusion Criteria

Exclusion Criteria

* Admitted into chemical treatment with opioid use being a reason for treatment;
* DSM-IV-TR diagnosis of OUD;
* Ability to provide informed consent;
* A minimum of a 6th grade reading level; and
* Able and willing to provide own contact information for follow-up visit(s).
* Age- and gender-matched to an OUD patient participant in the study;
* Ability to provide informed consent;
* A minimum of a 6th grade reading level;
* Able and willing to provide own contact information for follow-up visit(s).

* Refusal or inability to consent;
* Pregnant;
* History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures not caused by withdrawal from substances, Other \[please specify\]);
* Inability to see text and photos clearly on the computer display; and
* Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.
* Refusal or inability to consent;
* Pregnant;
* History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures, Other \[please specify\]);
* Inability to see text and photos clearly on the computer display;
* Current or previous problems using opioids, other prescription (prescribed or not prescribed) or illicit drugs;
* Regular nicotine user (e.g., cigarette smoker, e-cig user) within the past 12 months; and
* Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.

Contacts and Locations

Study Contact

Scott Burwell, PhD

CONTACT

612-790-9304

burwell@umn.edu

Scott Burwell, PhD

CONTACT

651-421-1696

scott@neurotype.io

Principal Investigator

Justin Anker, PhD

PRINCIPAL_INVESTIGATOR

University of Minnesota

Scott Burwell, PhD

STUDY_DIRECTOR

Neurotype Inc.

Study Locations (Sites)

University of Minnesota - Department of Psychiatry & Behavioral Health

Minneapolis, Minnesota, 55454

United States

Collaborators and Investigators

Sponsor: Neurotype Inc.

Justin Anker, PhD, PRINCIPAL_INVESTIGATOR, University of Minnesota
Scott Burwell, PhD, STUDY_DIRECTOR, Neurotype Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-17

Study Completion Date2025-08-31

Study Record Updates

Study Start Date2025-01-17

Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

biofeedback
neurofeedback
electroencephalogram
addiction
substance use disorder
opioid use disorder
attention
emotion regulation
event-related potential

Additional Relevant MeSH Terms

Opioid Use Disorder